2020 review – Pharma’s progress outside of COVID-19
pharmaphorum
DECEMBER 23, 2020
The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade. Biogen and Denali will co-market the lead LRRK2 product in the US and China, and Biogen will commercialise in all other markets.
Let's personalize your content